Carmel, IN, United States of America

Jingdan Hu

This inventor holds 7 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Elanco US Inc., Eli Lilly and Company, University of Notre Dame Du Lac. Active years: 2002-2026.

USPTO Granted Patents = 7 

% Patents Active = 71.4

 

Average Co-Inventor Count = 2.3

ph-index = 1


Company Filing History:


Years Active: 2002-2026

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Jingdan Hu

Introduction

Jingdan Hu is a notable inventor based in Carmel, Indiana, with a significant portfolio of six patents. His work primarily focuses on the development of chemical compounds and processes that have applications in pharmaceuticals.

Latest Patents

Among his latest patents is a process for making an isoxazoline compound and its intermediates. This patent details methods for producing enantiomerically pure isoxazoline compounds, specifically improving the enantiomeric purity of certain chemical structures through crystallization. Another significant patent involves the crystalline forms of a complex chemical compound, which includes pharmaceutical compositions and methods for their use.

Career Highlights

Jingdan Hu has made substantial contributions to the field of chemistry during his career. He has worked with prominent companies such as Elanco US Inc. and Eli Lilly and Company, where he has applied his expertise in developing innovative chemical solutions.

Collaborations

Throughout his career, Jingdan has collaborated with notable colleagues, including Timothy Andrew Woods and Jean Marie Defauw. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Jingdan Hu's innovative work in the field of chemistry and his contributions to pharmaceutical development highlight his importance as an inventor. His patents reflect a commitment to advancing chemical processes and improving the purity of compounds, showcasing his impact on the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…